Mitral Regurgitation: Volume Overload, Chamber Remodeling, and Functional Decline

Core Idea

Mitral regurgitation causes leftward displacement of the diastolic pressure-volume curve; the left atrium and ventricle dilate to accommodate the regurgitant volume. Eccentric hypertrophy and progressive chamber enlargement eventually exhaust compensatory mechanisms, leading to systolic dysfunction and pulmonary congestion.

Explainer

From the cardiac cycle, you know that the mitral valve opens during diastole to allow blood to fill the left ventricle from the left atrium, and snaps shut at the onset of systole so that ventricular contraction drives blood forward through the aortic valve. In mitral regurgitation (MR), the valve fails to close competently: with each systolic contraction, a fraction of the stroke volume leaks backward into the left atrium instead of being ejected forward. This seemingly simple mechanical failure sets off a chain of compensatory responses that, over years, remodel both chambers and eventually cause them to fail.

The immediate hemodynamic insult is volume overload. The left ventricle must now pump both the forward cardiac output and the regurgitant volume. To accommodate the extra volume without excessive pressure rise, the left ventricle dilates — the diastolic pressure-volume curve shifts rightward, allowing greater filling at the same filling pressure. This dilation is eccentric hypertrophy: the chamber enlarges by adding sarcomeres in series, so muscle fibers become longer rather than thicker. (Contrast this with the *concentric hypertrophy* of chronic pressure overload, where sarcomeres are added in parallel and the wall thickens without much chamber dilation.) For a period, the Frank-Starling mechanism helps: the well-filled, enlarged ventricle generates a hyperdynamic stroke volume. The ejection fraction often appears supranormal — 65–75% — which can falsely reassure the clinician.

This is where knowledge of your heart failure prerequisite becomes essential. The elevated ejection fraction in compensated MR is misleading because part of the stroke volume is ejecting into the low-resistance left atrium rather than against the high-resistance aorta. The afterload on the ventricle is artificially reduced by the regurgitant pathway. When cardiologists interpret EF in MR, they apply a higher threshold: an EF of 60% in MR may represent early myocardial decompensation in a ventricle that should, given its preload advantage, be generating an EF of 70%. Over years, chronic volume overload induces progressive myocardial fibrosis and contractile dysfunction. The left atrium also dilates under sustained volume and pressure load, creating the substrate for atrial fibrillation — which then removes the atrial kick that had been augmenting ventricular filling, worsening the volume overload spiral.

The clinical inflection point comes when myocardial contractile reserve is exhausted. The ejection fraction falls toward or below normal, end-systolic volume rises, and the regurgitant fraction may worsen as the now-dilated annulus makes the regurgitation more severe. Pulmonary venous pressure rises as the left atrium can no longer buffer the regurgitant jet, producing dyspnea. An end-systolic diameter exceeding 40 mm is used as a surgical trigger precisely because it is a more reliable marker of functional decline than EF alone. Timing surgery before irreversible myocardial dysfunction develops is the central challenge of MR management — and it requires serial echocardiographic surveillance to catch the inflection point that symptoms often lag behind by months to years.